Australian Pharmaceutical Industries Ltd (ASX:API) is the pharmacy company behind Priceline, ClearSkincare, Soul Pattinson Chemist and much more. The Melbourne-based company is more than 100 years old and operates more than 500 chemists and hundreds more are included in its member network. API is part-owned by Washington H. Soul Pattinson (ASX: SOL).
The S&P/ASX 200 (ASX: XJO) experienced a rare loss on Monday as SiteMinder (ASX:SDR) and Sydney Airport (ASX:SYD) shares made headlines.
Australian Pharmaceutical Industries Ltd (ASX: API) is set to be taken over Wesfarmers Ltd (ASX: WES) after a Scheme of Implementation was signed.
The Wesfarmers (ASX:WES) share price rose by 2% today as it’s in prime position to take over Australian Pharmaceutical Industries (ASX:API).
The Humm Group Ltd (ASX:HUM) share price is in focus after giving investors its FY22 first quarter update.
The S&P/ASX 200 (ASX:XJO) strengthened into the close on Monday as the Star Entertainment (ASX:SGR) share price collapsed.
Takeover target Australian Pharmaceutical Industries Ltd (ASX: API) share price is up marginally after the company upgraded profit guidance.
The resilient run of the S&P/ASX 200 (ASX: XJO) continued on Thursday as Collins Foods (ASX:CKF) and Sezzle (ASX:SZL) shares made headlines.
The battle for Australian Pharmaceutical (ASX: API) is heating up as Wesfarmers (ASX: WES) nab 19% stake in the local pharmacy chain.
The S&P/ASX 200 (ASX:XJO) posted a strong opening to the week on Monday. Wesfarmers (ASX:WES) and ASX travel shares are making headlines.